The global clopidogrel market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factors that are expected to accelerate the growth of the market during the forecast period include the increased demand for clopidogrel among patients who are suffering from CVD and related problems. Moreover, the changing lifestyle and increase in the number of patients related to cardiovascular diseases among the emerging economies in the Asia Pacific region are further expected to drive the market growth during the forecast period. Moreover, the patent expiry of clopidogrel drugs is anticipated to open possibilities for various pharmaceutical companies to venture into the production of clopidogrel drugs. 

Clopidogrel is an antiplatelet agent of thienopyridine, which is primarily used to prevent blood clots and support against CVD problems associated with blood clotting. The medications used for inhibiting blood clots after a recent heart stroke also involves the use of clopidogrel, which is a white-coloured powder that is insoluble in water at neutral pH, however, freely soluble at pH1. Sold under the brand name Plavix, and marketed by Sanofi and Bristol-Myers Squibb, the demand for clopidogrel is escalating owing to the increasing number of heart attack cases across the globe.  Furthermore, several other organizations such as Roxane Laboratories, Aurobindo Pharma Ltd., Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., and Apotex Inc., have gained approval for marketing clopidogrel 75mg. Clopidogrel is also used with aspirin to treat worsening chest pain and keep blood vessels open and prevent blood clots after certain heart-related operations.  According to the World Heart Federation, nearly 15 million people suffer from heart attack or related problems globally. Out of these, roughly six million of these patients die while another five million are disabled permanently. This vast patient base is the primary factor that will sustain the demand for clopidogrel during the forecast period. 

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally

Competitive Landscape: Sanofi S.A., Bristol Myers Squibb Co., and Sun Pharmaceutical Industries Ltd., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Clopidogrel Market Report by Segment

By Type

• 25 mg

• 75 mg

• 300 mg

By Application

• Hospitals

• Private Clinics

• Retail Pharmacies

• Online Pharmacies

• Others

Global Clopidogrel Market by Region